All Treatments articles
-
Industry newsMHRA authorises new cancer treatment variation with significantly reduced administration time
On 30 April 2025, the Medicines and Healthcare products Regulatory Agency (MHRA) authorised a new under-the-skin injection variation of nivolumab (OPDIVO). This offers a quicker administration of the treatment for eligible patients.
-
InterviewBengt Mattson reflects on sustainability
Bengt Mattson is Policy Manager at LiF, the trade association for the research-based pharmaceutical industry in Sweden. He is also the Co-chair of the three European pharmaceutical trade associations’ (AESGP, EFPIA and MfE) Task Force on pharmaceutical and environmental impacts. In this interview with Alan Booth, he reflects on sustainability in the regulatory environment.